Cargando…
What Happened to Electrocardiogram as a Screening Test to Recognize Cardiovascular Complications in COVID-19 Patients?
Autores principales: | Bertini, Matteo, Ferrari, Roberto, Rapezzi, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
the American College of Cardiology Foundation. Published by Elsevier.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704066/ https://www.ncbi.nlm.nih.gov/pubmed/33272378 http://dx.doi.org/10.1016/j.jacc.2020.09.611 |
Ejemplares similares
-
Reply: What Happened to Electrocardiogram as a Screening Test to Recognize Cardiovascular Complications in COVID-19 Patients?
por: Lala, Anuradha, et al.
Publicado: (2020) -
Endocrine complications of COVID-19: what happens to the thyroid and adrenal glands?
por: Bellastella, G., et al.
Publicado: (2020) -
COVID-19: what happened to all of the otolaryngology emergencies?
por: Gelardi, Matteo, et al.
Publicado: (2020) -
The Combination of Chest Computed Tomography and Standard Electrocardiogram Provides Prognostic Information and Pathophysiological Insights in COVID-19 Pneumonia
por: Bertini, Matteo, et al.
Publicado: (2021) -
Dengue Expansion in Africa—Not Recognized or Not Happening?
por: Jaenisch, Thomas, et al.
Publicado: (2014)